Our study also demonstrated that the activation of HF-CAR-PMs was dependent on the presence of HER2 antigen and the tumoricidal activity was enhanced with higher HER2 expression on the tumour cell surface (Supplementary Fig. S2B–L). The gene discussed is ERBB2; the disease is neoplasm.